![\"Lester](\"https:\/\/onellp.com\/wp-content\/uploads\/2024\/03\/Lester_Badges_Lester.png\")
\n<\/u><\/a>lsavit@onellp.com<\/u><\/a>
\n(949) 502-0482<\/u><\/a>
\nV-card<\/u><\/a>
\nLinkedIn<\/u><\/a><\/u><\/p>\n
Practice Areas<\/b><\/h6>\n\n\nIntellectual Property Litigation<\/h5>\n<\/div>\n<\/div>\n[\/vc_column_text][\/vc_column][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_spacing=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_shadow=”none” column_border_radius=”none” column_link_target=”_self” gradient_direction=”left_to_right” overlay_strength=”0.3″ width=”3\/4″ tablet_width_inherit=”default” tablet_text_alignment=”default” phone_text_alignment=”default” bg_image_animation=”none” border_type=”simple” column_border_width=”none” column_border_style=”solid”][vc_column_text]Lester Savit is a partner at\u00a0One LLP and a leading intellectual property attorney with\u00a0more than three decades of experience working with technology companies to protect and develop inventions,\u00a0patents<\/a>, trade secrets, trademarks, and good will.\u00a0 His clients include leading biotech and pharma companies\u00a0(Abbott Laboratories, Affymetrix, Celgene, Johnson & Johnson, Merz Pharma) and companies in the medical device, polymer, specialty chemical, semiconductor, electronics, and other industries.\u00a0 He was the founding partner of the\u00a0Intellectual Property Practice of Jones Day in Irvine, California.<\/p>\nWhenever possible, Lester\u00a0works with clients to resolve challenges and commercial disputes effectively without litigation.\u00a0\u00a0He is an experienced negotiator in addition to being a seasoned\u00a0arbitrator and mediator. He\u00a0works with\u00a0the American Arbitration Association in commerical disputes and serves on the National Panel of Patent Arbitrators.<\/p>\n
Lester\u00a0also aggressively represents clients in federal court litigation.\u00a0\u00a0\u00a0He led a\u00a0series of 10 patent infringement actions brought on behalf of a major biotech company against generic drug manufacturers\u00a0with such success that\u00a0these cases were\u00a0favorably settled. \u00a0Lester also advised a European company prior to its entry into the U.S. market, led a long-term patent enforcement program for another client, and\u00a0obtained judgments totaling more than $90 million for three others.\u00a0Savit is the only attorney in the country to have obtained a default judgment against a patent infringer as a sanction for discovery abuses.<\/p>\n
As a business-minded\u00a0expert in biotechnology law, he serves as\u00a0an adjunct professor at Pepperdine University School of Law, where he teaches \u201cLaw & Biotechnology.\u201d Lester also is a member of the\u00a0Dean\u2019s Advisory Board at the University of California, Irvine\u00a0Paul Merage School of Business.<\/a>\u00a0The Board serves as the Merage School\u2019s primary advisory body responsible for providing perspective and counsel for academic and professional programs and includes top management from companies throughout Southern California. Savit also serves as chair of the Merage School\u00a0Corporate Partners Program<\/a>\u00a0Executive Steering Committee.<\/p>\nLester\u00a0served as a board member of the Federal Bar Association, Orange County Chapter for several years, a member of the Phoenix Society of the University of Chicago and is often invited to speak on intellectual property and litigation topics such as the patentability of human genetic sequences, electronic discovery, arbitration\/mediation\u00a0and intellectual property crimes.<\/p>\n
Speaking Engagements<\/strong><\/h2>\n\n- April 4, 2012 \u2013 \u00a0Lester Savit spoke to over thirty members of the Oregon State Bar, Intellectual Property Law Section, at the Ace Hotel in Portland about Patent Monetization.<\/li>\n
- February 17, 2012 \u2013 One LLP partner Lester J. Savit addressed 35 faculty members, post-docs, and graduate students at the University of California, Irvine\u2019s Sue and Bill Gross Stem Cell Research Center. \u00a0Mr. Savit\u2019s hour-long lecture was entitled, \u201cStem Cell Research: \u00a0Federal Funding and Intellectual Property Issues.\u201d \u00a0The event was part of a course designed for the stem cell research community as well as scientists and students throughout the campus with an interest in this nascent technology. \u00a0Invitations were distributed to various departments including MBA students at The Paul Merage School of Business and JD degree candidates at UCI\u2019s Law School. \u00a0Mr. Savit serves on the Merage School\u2019s Dean\u2019s Advisory Board and as chair of the Executive Committee of its Corporate Partner Program. \u00a0In addition, he is an adjunct law professor at Pepperdine University School of Law in Malibu, California, where he has taught \u201cLaw and Biotechnology\u201d since 2004.<\/li>\n
- January 17, 2012 \u2013 Lester Savit was a guest on The Docket with Evan Simon, a radio program that explores legal topics.<\/li>\n
- October 13, 2011 -Expert panelist for \u201cMuscular Arbitration: Trimming the Fat out of Arbitration\u201d co-sponsored by American Arbitration Association and University of California, Irvine Law School<\/li>\n
- September 22, 2011 \u2013 Featured guest on \u201cThe Docket\u201d (KUCI 88.9 FM and internet simulcast) speaking on United States v. Wesley DeSoto and fair use copyright issues and the Leahy-Smith America Invents Act<\/li>\n
- January 22, 2010 \u2013 Bend or Break: Tailoring the Patent System to Promote Innovation, panel moderator Irvine, California<\/li>\n
- November 19, 2009 \u2013 Interview with Professor Dan Burk of the University of California, Irvine School of Law, regarding patentability of computer software, \u201cThe Docket\u201d ( KUCI 88.9 FM and internet simulcast)<\/li>\n
- August 12, 2007 \u2013 Who Owns Your Genes? panel with Michael Crichton, author and medical doctor, and Lori Andrews, Director of the Science and Technology Institute of Law in Illinois, ABA National Meeting San Francisco, California<\/li>\n
- November 13, 2006 \u2013 Patent Strategies for Medical Devices \u2013 The 3rd Annual UCI Medical Device Conference Irvine, California<\/li>\n
- April 4, 2006 \u2013 Panel Discussion With District Court Judge Schira A. Scheindlin, Author of the Zubulake Opinions, at ACC-SoCal Doubleheader Los Angeles, California<\/li>\n
- May 19, 2005 \u2013 Electronic Discovery in the Federal Courts, panel moderator, Federal Bar Association, Orange County Chapter Santa Ana, California<\/li>\n
- January 20, 2005 \u2013 Stem Cell Research: California Economic Boom or Federal Criminal Bust, Intellectual Property Lecture Series, Whittier Law School Costa Mesa, California<\/li>\n
- October 20, 2004 \u2013 Intellectual Property Crimes: What You Need to Know to Prevent Them and Stay Out of Trouble Los Angeles, Beverly Hills, California<\/li>\n
- February 19, 2003 \u2013 E-Discovery, ACCA Lecture Series Torrence, California<\/li>\n
- July 11, 2002 \u2013 Protecting Biotech Inventions, Summer IP Institute, Whittier Law School Costa Mesa, California<\/li>\n
- October 9, 2001 \u2013 E-Discovery: What you need to know and do NOW to avoid costly surprises, Orange County Bar Association, In-House Counsel Section Orange County, California<\/li>\n<\/ul>\n
Selected Cases\u00a0<\/strong>(Including 25-year career at Jones Day)<\/h2>\n\n- Celgene licenses patents to Teva for marketing generic version of Focalin capsules and tablets<\/li>\n
- Celgene files patent suit against KV Pharmaceuticals over generic version of Focalin XR\u00aeMolex obtains $1.8 million judgment in patent suit involving electrical connectors<\/li>\n
- Independent director successfully defends shareholder derivative action<\/li>\n
- DIRECTV successfully defends against claims of patent infringement involving DVRs<\/li>\n
- Celgene files patent infringement suit against Barr Labs over generic version of ADHD drug Focalin XR\u00ae<\/li>\n
- Celgene files patent infringement charges against Actavis and Abrika over generic versions of ADHD drug Focalin XR\u00ae<\/li>\n
- Celgene lodges patent infringement charges against Barr Labs over generic version of Ritalin LA\u00ae<\/li>\n
- Celgene pursues patent infringement litigation against KV Pharmaceutical concerning Ritalin LA\u00ae<\/li>\n
- Celgene pursues patent infringement litigation against Teva concerning Focalin XR\u00ae<\/li>\n
- Celgene pursues patent infringement litigation against Abrika concerning Ritalin LA\u00ae<\/li>\n
- Simmons defends against patent and trademark infringement charges brought by rival Serta<\/li>\n
- Cardiac Science settles favorably in patent infringement action concerning automatic electronic defibrillator technology<\/li>\n
- Dense-Pac Microsystems pursues patent infringement action relating to microchip stacking technology<\/li>\n
- Motorola and Freescale resolve patent infringement suit brought by Analog Devices involving microchip fabrication<\/li>\n
- Celgene files patent infringement suit against generic drug maker Teva Pharmaceuticals over ADHD drugs<\/li>\n
- astman Kodak summary judgment win in patent infringement action involving lenticular products is affirmed by Federal Circuit<\/li>\n
- Abbott seeks infringement charges against Geneva concerning HYTRIN\u00ae antihypertensive drug patent<\/li>\n
- Marconi wins $9 million judgment for infringement of patents on inkjet technology<\/li>\n
- DePuy Spine wins $52 MM in patent infringement suit over spinal implant devices<\/li>\n
- Johnson & Johnson company defends against patent infringement allegations for spinal implant technology<\/li>\n
- Abbott wins summary judgment in patent infringement action to prevent FDA approval of generic version of Depakote\u00ae<\/li>\n
- Eastman Kodak prevails in action against Goodyear for infringement of patent relating to PET manufacturing process<\/li>\n
- Scotts Company defends against patent infringement charges involving controlled release fertilizers<\/li>\n<\/ul>\n
Memberships<\/h2>\n\n- Board Member, HD-CARE\u00a02015-Present<\/li>\n
- Board Member, Howard T. Markey Intellectual Property Inn of Court, 2015-Present<\/li>\n
- President, Laguna North Neighborhood Organization, 2013-Present<\/li>\n
- Adjunct Professor of Law, Pepperdine University School of Law, 2004-Present<\/li>\n
- Panel Mediator, United States District Court, Central District of California, 2007-Present<\/li>\n
- Arbitrator, American Arbitration Association (Commercial Dispute Roster), 2006-Present<\/li>\n
- Executive Committee, Corporate Partners, The Paul Merage School of Business, University of California, Irvine, 2009-Present<\/li>\n<\/ul>\n
Articles<\/strong><\/h2>\n\n- Restrictions on the Use of Copyrighted Computer Software and Music CDs: The Ninth Circuit Clarifies the Law in a Trilogy of Decisions<\/a><\/li>\n
- Successful Biosimilars Patent Litigation Strategy is Foreshadowed in Momenta Pharmaceuticals, Inc. v. Amphastar Pharmaceuticals, Inc.<\/a><\/li>\n
- Interview with United States District Judge James V. Selna<\/a><\/li>\n
- Interview with United States District Court Judge Andrew Guilford<\/a><\/li>\n
- Interview with United States District Court Judge Cormac J. Carney<\/a><\/li>\n<\/ul>\n[\/vc_column_text][\/vc_column][\/vc_row][vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_spacing=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_shadow=”none” column_border_radius=”none” column_link_target=”_self” gradient_direction=”left_to_right” overlay_strength=”0.3″ width=”1\/1″ tablet_width_inherit=”default” tablet_text_alignment=”default” phone_text_alignment=”default” bg_image_animation=”none” border_type=”simple” column_border_width=”none” column_border_style=”solid”][vc_column_text]\n[\/vc_column_text][\/vc_column][\/vc_row]\n","protected":false},"featured_media":1182,"template":"","practice_areas":[19,20,29,31,25,24,27,34],"locations":[15],"_links":{"self":[{"href":"https:\/\/onellp.com\/wp-json\/wp\/v2\/attorney\/1181"}],"collection":[{"href":"https:\/\/onellp.com\/wp-json\/wp\/v2\/attorney"}],"about":[{"href":"https:\/\/onellp.com\/wp-json\/wp\/v2\/types\/attorney"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/onellp.com\/wp-json\/wp\/v2\/media\/1182"}],"wp:attachment":[{"href":"https:\/\/onellp.com\/wp-json\/wp\/v2\/media?parent=1181"}],"wp:term":[{"taxonomy":"practice_areas","embeddable":true,"href":"https:\/\/onellp.com\/wp-json\/wp\/v2\/practice_areas?post=1181"},{"taxonomy":"locations","embeddable":true,"href":"https:\/\/onellp.com\/wp-json\/wp\/v2\/locations?post=1181"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
Intellectual Property Litigation<\/h5>\n<\/div>\n<\/div>\n[\/vc_column_text][\/vc_column][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_spacing=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_shadow=”none” column_border_radius=”none” column_link_target=”_self” gradient_direction=”left_to_right” overlay_strength=”0.3″ width=”3\/4″ tablet_width_inherit=”default” tablet_text_alignment=”default” phone_text_alignment=”default” bg_image_animation=”none” border_type=”simple” column_border_width=”none” column_border_style=”solid”][vc_column_text]Lester Savit is a partner at\u00a0One LLP and a leading intellectual property attorney with\u00a0more than three decades of experience working with technology companies to protect and develop inventions,\u00a0patents<\/a>, trade secrets, trademarks, and good will.\u00a0 His clients include leading biotech and pharma companies\u00a0(Abbott Laboratories, Affymetrix, Celgene, Johnson & Johnson, Merz Pharma) and companies in the medical device, polymer, specialty chemical, semiconductor, electronics, and other industries.\u00a0 He was the founding partner of the\u00a0Intellectual Property Practice of Jones Day in Irvine, California.<\/p>\nWhenever possible, Lester\u00a0works with clients to resolve challenges and commercial disputes effectively without litigation.\u00a0\u00a0He is an experienced negotiator in addition to being a seasoned\u00a0arbitrator and mediator. He\u00a0works with\u00a0the American Arbitration Association in commerical disputes and serves on the National Panel of Patent Arbitrators.<\/p>\n
Lester\u00a0also aggressively represents clients in federal court litigation.\u00a0\u00a0\u00a0He led a\u00a0series of 10 patent infringement actions brought on behalf of a major biotech company against generic drug manufacturers\u00a0with such success that\u00a0these cases were\u00a0favorably settled. \u00a0Lester also advised a European company prior to its entry into the U.S. market, led a long-term patent enforcement program for another client, and\u00a0obtained judgments totaling more than $90 million for three others.\u00a0Savit is the only attorney in the country to have obtained a default judgment against a patent infringer as a sanction for discovery abuses.<\/p>\n
As a business-minded\u00a0expert in biotechnology law, he serves as\u00a0an adjunct professor at Pepperdine University School of Law, where he teaches \u201cLaw & Biotechnology.\u201d Lester also is a member of the\u00a0Dean\u2019s Advisory Board at the University of California, Irvine\u00a0Paul Merage School of Business.<\/a>\u00a0The Board serves as the Merage School\u2019s primary advisory body responsible for providing perspective and counsel for academic and professional programs and includes top management from companies throughout Southern California. Savit also serves as chair of the Merage School\u00a0Corporate Partners Program<\/a>\u00a0Executive Steering Committee.<\/p>\nLester\u00a0served as a board member of the Federal Bar Association, Orange County Chapter for several years, a member of the Phoenix Society of the University of Chicago and is often invited to speak on intellectual property and litigation topics such as the patentability of human genetic sequences, electronic discovery, arbitration\/mediation\u00a0and intellectual property crimes.<\/p>\n
Speaking Engagements<\/strong><\/h2>\n\n- April 4, 2012 \u2013 \u00a0Lester Savit spoke to over thirty members of the Oregon State Bar, Intellectual Property Law Section, at the Ace Hotel in Portland about Patent Monetization.<\/li>\n
- February 17, 2012 \u2013 One LLP partner Lester J. Savit addressed 35 faculty members, post-docs, and graduate students at the University of California, Irvine\u2019s Sue and Bill Gross Stem Cell Research Center. \u00a0Mr. Savit\u2019s hour-long lecture was entitled, \u201cStem Cell Research: \u00a0Federal Funding and Intellectual Property Issues.\u201d \u00a0The event was part of a course designed for the stem cell research community as well as scientists and students throughout the campus with an interest in this nascent technology. \u00a0Invitations were distributed to various departments including MBA students at The Paul Merage School of Business and JD degree candidates at UCI\u2019s Law School. \u00a0Mr. Savit serves on the Merage School\u2019s Dean\u2019s Advisory Board and as chair of the Executive Committee of its Corporate Partner Program. \u00a0In addition, he is an adjunct law professor at Pepperdine University School of Law in Malibu, California, where he has taught \u201cLaw and Biotechnology\u201d since 2004.<\/li>\n
- January 17, 2012 \u2013 Lester Savit was a guest on The Docket with Evan Simon, a radio program that explores legal topics.<\/li>\n
- October 13, 2011 -Expert panelist for \u201cMuscular Arbitration: Trimming the Fat out of Arbitration\u201d co-sponsored by American Arbitration Association and University of California, Irvine Law School<\/li>\n
- September 22, 2011 \u2013 Featured guest on \u201cThe Docket\u201d (KUCI 88.9 FM and internet simulcast) speaking on United States v. Wesley DeSoto and fair use copyright issues and the Leahy-Smith America Invents Act<\/li>\n
- January 22, 2010 \u2013 Bend or Break: Tailoring the Patent System to Promote Innovation, panel moderator Irvine, California<\/li>\n
- November 19, 2009 \u2013 Interview with Professor Dan Burk of the University of California, Irvine School of Law, regarding patentability of computer software, \u201cThe Docket\u201d ( KUCI 88.9 FM and internet simulcast)<\/li>\n
- August 12, 2007 \u2013 Who Owns Your Genes? panel with Michael Crichton, author and medical doctor, and Lori Andrews, Director of the Science and Technology Institute of Law in Illinois, ABA National Meeting San Francisco, California<\/li>\n
- November 13, 2006 \u2013 Patent Strategies for Medical Devices \u2013 The 3rd Annual UCI Medical Device Conference Irvine, California<\/li>\n
- April 4, 2006 \u2013 Panel Discussion With District Court Judge Schira A. Scheindlin, Author of the Zubulake Opinions, at ACC-SoCal Doubleheader Los Angeles, California<\/li>\n
- May 19, 2005 \u2013 Electronic Discovery in the Federal Courts, panel moderator, Federal Bar Association, Orange County Chapter Santa Ana, California<\/li>\n
- January 20, 2005 \u2013 Stem Cell Research: California Economic Boom or Federal Criminal Bust, Intellectual Property Lecture Series, Whittier Law School Costa Mesa, California<\/li>\n
- October 20, 2004 \u2013 Intellectual Property Crimes: What You Need to Know to Prevent Them and Stay Out of Trouble Los Angeles, Beverly Hills, California<\/li>\n
- February 19, 2003 \u2013 E-Discovery, ACCA Lecture Series Torrence, California<\/li>\n
- July 11, 2002 \u2013 Protecting Biotech Inventions, Summer IP Institute, Whittier Law School Costa Mesa, California<\/li>\n
- October 9, 2001 \u2013 E-Discovery: What you need to know and do NOW to avoid costly surprises, Orange County Bar Association, In-House Counsel Section Orange County, California<\/li>\n<\/ul>\n
Selected Cases\u00a0<\/strong>(Including 25-year career at Jones Day)<\/h2>\n\n- Celgene licenses patents to Teva for marketing generic version of Focalin capsules and tablets<\/li>\n
- Celgene files patent suit against KV Pharmaceuticals over generic version of Focalin XR\u00aeMolex obtains $1.8 million judgment in patent suit involving electrical connectors<\/li>\n
- Independent director successfully defends shareholder derivative action<\/li>\n
- DIRECTV successfully defends against claims of patent infringement involving DVRs<\/li>\n
- Celgene files patent infringement suit against Barr Labs over generic version of ADHD drug Focalin XR\u00ae<\/li>\n
- Celgene files patent infringement charges against Actavis and Abrika over generic versions of ADHD drug Focalin XR\u00ae<\/li>\n
- Celgene lodges patent infringement charges against Barr Labs over generic version of Ritalin LA\u00ae<\/li>\n
- Celgene pursues patent infringement litigation against KV Pharmaceutical concerning Ritalin LA\u00ae<\/li>\n
- Celgene pursues patent infringement litigation against Teva concerning Focalin XR\u00ae<\/li>\n
- Celgene pursues patent infringement litigation against Abrika concerning Ritalin LA\u00ae<\/li>\n
- Simmons defends against patent and trademark infringement charges brought by rival Serta<\/li>\n
- Cardiac Science settles favorably in patent infringement action concerning automatic electronic defibrillator technology<\/li>\n
- Dense-Pac Microsystems pursues patent infringement action relating to microchip stacking technology<\/li>\n
- Motorola and Freescale resolve patent infringement suit brought by Analog Devices involving microchip fabrication<\/li>\n
- Celgene files patent infringement suit against generic drug maker Teva Pharmaceuticals over ADHD drugs<\/li>\n
- astman Kodak summary judgment win in patent infringement action involving lenticular products is affirmed by Federal Circuit<\/li>\n
- Abbott seeks infringement charges against Geneva concerning HYTRIN\u00ae antihypertensive drug patent<\/li>\n
- Marconi wins $9 million judgment for infringement of patents on inkjet technology<\/li>\n
- DePuy Spine wins $52 MM in patent infringement suit over spinal implant devices<\/li>\n
- Johnson & Johnson company defends against patent infringement allegations for spinal implant technology<\/li>\n
- Abbott wins summary judgment in patent infringement action to prevent FDA approval of generic version of Depakote\u00ae<\/li>\n
- Eastman Kodak prevails in action against Goodyear for infringement of patent relating to PET manufacturing process<\/li>\n
- Scotts Company defends against patent infringement charges involving controlled release fertilizers<\/li>\n<\/ul>\n
Memberships<\/h2>\n\n- Board Member, HD-CARE\u00a02015-Present<\/li>\n
- Board Member, Howard T. Markey Intellectual Property Inn of Court, 2015-Present<\/li>\n
- President, Laguna North Neighborhood Organization, 2013-Present<\/li>\n
- Adjunct Professor of Law, Pepperdine University School of Law, 2004-Present<\/li>\n
- Panel Mediator, United States District Court, Central District of California, 2007-Present<\/li>\n
- Arbitrator, American Arbitration Association (Commercial Dispute Roster), 2006-Present<\/li>\n
- Executive Committee, Corporate Partners, The Paul Merage School of Business, University of California, Irvine, 2009-Present<\/li>\n<\/ul>\n
Articles<\/strong><\/h2>\n\n- Restrictions on the Use of Copyrighted Computer Software and Music CDs: The Ninth Circuit Clarifies the Law in a Trilogy of Decisions<\/a><\/li>\n
- Successful Biosimilars Patent Litigation Strategy is Foreshadowed in Momenta Pharmaceuticals, Inc. v. Amphastar Pharmaceuticals, Inc.<\/a><\/li>\n
- Interview with United States District Judge James V. Selna<\/a><\/li>\n
- Interview with United States District Court Judge Andrew Guilford<\/a><\/li>\n
- Interview with United States District Court Judge Cormac J. Carney<\/a><\/li>\n<\/ul>\n[\/vc_column_text][\/vc_column][\/vc_row][vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_spacing=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_shadow=”none” column_border_radius=”none” column_link_target=”_self” gradient_direction=”left_to_right” overlay_strength=”0.3″ width=”1\/1″ tablet_width_inherit=”default” tablet_text_alignment=”default” phone_text_alignment=”default” bg_image_animation=”none” border_type=”simple” column_border_width=”none” column_border_style=”solid”][vc_column_text]\n[\/vc_column_text][\/vc_column][\/vc_row]\n","protected":false},"featured_media":1182,"template":"","practice_areas":[19,20,29,31,25,24,27,34],"locations":[15],"_links":{"self":[{"href":"https:\/\/onellp.com\/wp-json\/wp\/v2\/attorney\/1181"}],"collection":[{"href":"https:\/\/onellp.com\/wp-json\/wp\/v2\/attorney"}],"about":[{"href":"https:\/\/onellp.com\/wp-json\/wp\/v2\/types\/attorney"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/onellp.com\/wp-json\/wp\/v2\/media\/1182"}],"wp:attachment":[{"href":"https:\/\/onellp.com\/wp-json\/wp\/v2\/media?parent=1181"}],"wp:term":[{"taxonomy":"practice_areas","embeddable":true,"href":"https:\/\/onellp.com\/wp-json\/wp\/v2\/practice_areas?post=1181"},{"taxonomy":"locations","embeddable":true,"href":"https:\/\/onellp.com\/wp-json\/wp\/v2\/locations?post=1181"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
Lester\u00a0served as a board member of the Federal Bar Association, Orange County Chapter for several years, a member of the Phoenix Society of the University of Chicago and is often invited to speak on intellectual property and litigation topics such as the patentability of human genetic sequences, electronic discovery, arbitration\/mediation\u00a0and intellectual property crimes.<\/p>\n